Fecal immunological test results and diagnostic colonoscopy in a Mexican population at average risk for colorectal cancer
Colorectal cancer (CRC) is a preventable and treatable with screening and early detection. Fecal immunochemical test (FIT) for average risk individuals is an effective strategy for screening. The incidence and mortality in Mexico has increased and large-scale screening program does not exist. The objective is to evaluate the feasibility of the FIT-based CRC screening program in Mexico City. For 15 months, the average risk individuals in Mexico City were invited to participate in the Mexican National Cancer Institute (Inca).
Participants receive FIT kit for collection of stool, the result ≥20ng / mL was referred to the high quality colonoscopy. Participants were classified according to the results of the most advanced clinical findings as: adenocarcinoma, adenoma, high risk, low risk adenomas, serrated lesions, hyperplastic polyps and no polyps. sequential analysis was performed to assess the positive predictive value (PPV) of the FIT. Eight hundred and ten participants were eligible, 737 (91.0%) returns FIT and 112 (15.2%) had abnormal results. Of the participants, 87 (77.7%) completed colonoscopy.
Clinical findings from participants included: 7 (8.1%) adenocarcinomas, 18 (20.7%) high-risk adenomas, 23 (26.4%) low-risk adenoma, 1 (1.2%) serrated lesions, 14 ( 16.1%) hyperplasic polyps, and 24 (27.6%) no polyps. PPV of FIT using the ≥20ng / mL was 8.1% for cancer and 20.7% for high-risk adenomas. In conclusion CRC screening with FIT worth Inka in Mexico City, where the available resources. Further studies are needed to determine the feasibility of CRC screening in other settings, as well as the optimal detection points hemoglobin cutoff to maximize the benefits of CRC screening with FIT population in Mexico.
the rapid spread of the coronavirus disease in 2019 (COVID-19) swept the world. Since the first report in December 2019 COVID-19 case has exploded to over 14 million in July 2020, claiming more than 600,000 lives. Applying a quick and comprehensive diagnostic test is essential to contain COVID-19, given the current lack of an effective vaccine or therapeutic. This review focuses on a comprehensive description of current diagnostic tests are available to detect both immune response virus (SARS-CoV-2) or virus-induced. We specifically explain the mechanism of action of this test and compare the performance of their analysis.
This analysis will help in selecting the most effective test for certain applications, for example, epidemiology, or the study of global pandemics, population screening, hospital-based testing, home-based testing and point-of-care, and therapeutic trials. Finally, we lay out the shortcomings of certain tests and future needs.
Clinical and immunological profile of Disease Mixed Connective Network and Comparison of Four Diagnostic Criteria.
mixed connective tissue disease (MCTD) was originally described as an immune-mediated chronic diseases with overlapping features of systemic lupus erythematosus, scleroderma and polymyositis. We conducted a cross-sectional study to describe the clinical and immunological profile of patients with MCTD and compare four diagnostic criteria, ie, criteria Sharp, Kasukawa, Alarcón-Segovia, and Khan.
19 mm Diameter Solid Titanium Tip |
|||
0-120-0013 | Biologics | 19 mm | EUR 570 |
25 mm Diameter Tapped Titanium Tip |
|||
0-120-0014 | Biologics | 25 mm | EUR 682 |
25 mm Diameter Solid Titanium Tip |
|||
0-120-0015 | Biologics | 25 mm | EUR 614 |
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
0-120-0016 | Biologics | 13 mm | EUR 86 |
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
0-120-0017 | Biologics | 19 mm | EUR 92 |
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
0-120-0018 | Biologics | 25 mm | EUR 100 |
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
Titanium Cup Tip, 250 ml |
|||
0-120-0019 | Biologics | 250 ml | EUR 1377 |
Description: includes Interface Washers |
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
0-120-0021 | Biologics | each | EUR 113 |
Description: includes Interface Washers |
Continuous Flow Chamber |
|||
0-120-0026 | Biologics | each | EUR 774 |
Description: includes Interface Washers |
Interface Washers 1.5” Diameter, 5/Pkg |
|||
0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
0-120-0038 | Biologics | 1.5 ml | EUR 152 |
Description: Thermo conductive tube pods |
KoldPod, 15ml Conical Tube |
|||
0-120-0039 | Biologics | 15 ml | EUR 275 |
Description: Thermo conductive tube pods |
KoldPod, 50ml Conical Tube |
|||
0-120-0040 | Biologics | 50 ml | EUR 290 |
Description: Thermo conductive tube pods |
Model 150 V/T Ultrasonic Homogenizer |
|||
0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
Model 300 V/T Ultrasonic Homogenizer |
|||
0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
SONABOZ Sound Abating Chamber |
|||
0-125-0001 | Biologics | each | EUR 1020 |
Description: Reduces cavitational sound emitted during processing. |
Model 3000 Ultrasonic Homogenizer |
|||
0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
Model 3000MP Ultrasonic Homogenizer |
|||
0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
Peni Cylinder Dispenser with Manual Hopper |
|||
0-144-0002 | Biologics | each | EUR 5406 |
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
Stainless Steel Peni Cylinder with Flat Face |
|||
0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
Description: sold in packages of 100 pieces |
Stainless Steel Peni Cylinder with Chamfered Face |
|||
0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
Description: sold in packages of 100 pieces |
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
00002 | Biotium | 1UG | EUR 527 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-bungarotoxin, CF405s |
|||
00002 | Cusabio | 500uG | EUR 594 |
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
00002-100ug | Biotium | 100uG | EUR 132 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
9-00003 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
9-00003 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
9-00004 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
9-00004 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
9-00005 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
9-00005 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
9-00006 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
9-00006 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
9-00007 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
9-00007 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
9-00009 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
9-00009 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
Alpha-Bungarotoxin, 1 mg |
|||
00010-1 | Biotium | 1MG | EUR 193 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, 1 mg |
|||
00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
00011 | Biotium | 500uG | EUR 376 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
00012 | Biotium | 500uG | EUR 394 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
00013 | Biotium | 10ST | EUR 436 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
00014 | Biotium | 10ST | EUR 494 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
00015 | Biotium | 500uG | EUR 494 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
00016 | Biotium | 10ST | EUR 560 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
00017 | Biotium | 500uG | EUR 455 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
9-00018 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
9-00018 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Acrylamide, Chemzymes Ultra Pure® |
|||
00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
Description: 79-06-1 |
Acrylamide, Chemzymes Ultra Pure® |
|||
00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
Description: 79-06-1 |
Biotin-cAMP, 1 mg |
|||
00020 | Biotium | 1MG | EUR 298 |
Description: N/A |
Biotin-cAMP, 1 mg |
|||
00020-1 | Biotium | 20ST | EUR 298 |
Description: N/A |
Biotin-cAMP, 50 ug |
|||
00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
00021 | Biotium | 1MG | EUR 331 |
Description: N/A |
Biotin-cGMP, 1 mg |
|||
00021-1 | Biotium | 20ST | EUR 331 |
Description: N/A |
Biotin-cGMP, 20x50 ug |
|||
00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
00022 | Biotium | 1MG | EUR 496 |
Description: N/A |
Cyanine 644-cAMP, 1 mg |
|||
00022-1 | Biotium | 20ST | EUR 496 |
Description: N/A |
Cyanine 644-cAMP, 20x50 ug |
|||
00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
00023 | Biotium | 1MG | EUR 285 |
Description: N/A |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
00023-1 | Biotium | EA | EUR 285 |
Staurosporine |
|||
00025 | Biotium | 100uG | EUR 100 |
Description: N/A |
Staurosporine |
|||
00025-1 | Biotium | EA | EUR 100 |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
00026 | Biotium | 500uG | EUR 527 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
00026-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®543, 100 ug |
|||
00026-100ug | Biotium | 1UG | EUR 132 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Rhodamine Phalloidin 300U |
|||
00027 | Biotium | 300 | EUR 364 |
Description: N/A |
Rhodamine Phalloidin 300U |
|||
00027-1 | Biotium | EA | EUR 364 |
Biotin-XX-Phalloidin |
|||
00028 | Biotium | 100U | EUR 466 |
Description: N/A |
Biotin-XX-Phalloidin |
|||
00028-1 | Biotium | EA | EUR 466 |
Fluorescein-Phalloidin |
|||
00030 | Biotium | 300U | EUR 364 |
Description: N/A |
Fluorescein-Phalloidin |
|||
00030-1 | Biotium | EA | EUR 364 |
Rhodamine 110 Phalloidin |
|||
00032 | Biotium | 300ST | EUR 364 |
Description: N/A |
Rhodamine 110 Phalloidin |
|||
00032-1 | Biotium | EA | EUR 364 |
Sulforhodamine 101 (Texas Red®) Phalloidin |
|||
00033 | Biotium | 300EU | EUR 364 |
Description: N/A |
Sulforhodamine 101 (Texas Red®) Phalloidin |
|||
00033-1 | Biotium | EA | EUR 364 |
Phalloidin, CF®405M |
|||
00034 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®405M |
|||
00034-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®405M |
|||
00034-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®405M |
|||
00034-T-1 | Biotium | EA | EUR 101 |
CF®488A-cAMP |
|||
00036 | Biotium | 100ug | EUR 136 |
Description: N/A |
CF®488A-cAMP |
|||
00036-1 | Biotium | EA | EUR 136 |
CF®640R-cAMP |
|||
00037 | Biotium | 100ug | EUR 136 |
Description: N/A |
CF®640R-cAMP |
|||
00037-1 | Biotium | EA | EUR 136 |
Phalloidin, CF555 |
|||
00040 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF555 |
|||
00040-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF®647, 300 U |
|||
00041 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®647, 300 U |
|||
00041-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®647, 50 U |
|||
00041-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®647, 50 U |
|||
00041-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®488A, 300 U |
|||
00042 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®488A, 300 U |
|||
00042-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®488A, 50 U |
|||
00042-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®488A, 50 U |
|||
00042-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®543, 300 U |
|||
00043 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®543, 300 U |
|||
00043-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®543, 50 U |
|||
00043-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®543, 50 U |
|||
00043-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®568, 300 U |
|||
00044 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®568, 300 U |
|||
00044-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®568, 50 U |
|||
00044-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®568, 50 U |
|||
00044-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®594, 300 U |
|||
00045 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®594, 300 U |
|||
00045-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®594, 50 U |
|||
00045-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®594, 50 U |
|||
00045-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®633, 300 U |
|||
00046 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®633, 300 U |
|||
00046-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®633, 50 U |
|||
00046-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®633, 50 U |
|||
00046-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®660R, 300 U |
|||
00047 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®660R, 300 U |
|||
00047-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®660R, 50 U |
|||
00047-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®660R, 50 U |
|||
00047-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®680R, 300 U |
|||
00048 | Biotium | 300U | EUR 513 |
Description: N/A |
Phalloidin, CF®680R, 300 U |
|||
00048-1 | Biotium | EA | EUR 513 |
Phalloidin, CF®680R, 50 U |
|||
00048-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®680R, 50 U |
|||
00048-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®350, 300 U |
|||
00049 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®350, 300 U |
|||
00049-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®350, 50 U |
|||
00049-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®350, 50 U |
|||
00049-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®640R, 300 U |
|||
00050 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®640R, 300 U |
|||
00050-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®640R, 50 U |
|||
00050-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®640R, 50 U |
|||
00050-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®532, 300 U |
|||
00051 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®532, 300 U |
|||
00051-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®532, 50 U |
|||
00051-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®532, 50 U |
|||
00051-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®660C, 300 U |
|||
00052 | Biotium | 300U | EUR 482 |
Description: N/A |
Phalloidin, CF®660C, 300 U |
|||
00052-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®660C, 50 U |
|||
00052-T | Biotium | 50U | EUR 101 |
Description: N/A |
Phalloidin, CF®660C, 50 U |
|||
00052-T-1 | Biotium | EA | EUR 101 |
Phalloidin, CF®680, 300 U |
|||
00053 | Biotium | 300U | EUR 513 |
Description: N/A |
Phalloidin, CF®680, 300 U |
|||
00053-1 | Biotium | EA | EUR 513 |
Phalloidin, CF®680, 50 U |
|||
00053-T | Biotium | 50U | EUR 118 |
Description: N/A |
Phalloidin, CF®680, 50 U |
|||
00053-T-1 | Biotium | EA | EUR 118 |
Phalloidin, CF®430, 300 U |
|||
00054 | Biotium | 300U | EUR 491 |
Description: N/A |
Phalloidin, CF®430, 300 U |
|||
00054-1 | Biotium | EA | EUR 491 |
Phalloidin, CF®430, 50 U |
|||
00054-T | Biotium | 50U | EUR 110 |
Description: N/A |
Phalloidin, CF®430, 50 U |
|||
00054-T-1 | Biotium | EA | EUR 110 |
Phalloidin, CF®440, 300 U |
|||
00055 | Biotium | 300U | EUR 491 |
Description: N/A |
Phalloidin, CF®440, 300 U |
|||
00055-1 | Biotium | EA | EUR 491 |
Phalloidin, CF®440, 50 U |
|||
00055-T | Biotium | 50U | EUR 110 |
Description: N/A |
Phalloidin, CF®440, 50 U |
|||
00055-T-1 | Biotium | EA | EUR 110 |
Phalloidin, CF®583R, 300 U |
|||
00064 | Biotium | 1U | EUR 482 |
Description: N/A |
Phalloidin, CF®583R, 300 U |
|||
00064-1 | Biotium | EA | EUR 482 |
Phalloidin, CF®583R, 50 U |
|||
00064-T | Biotium | 1U | EUR 108 |
Description: N/A |
Phalloidin, CF®583R, 50 U |
|||
00064-T-1 | Biotium | EA | EUR 108 |
Cholera Toxin B, CF®405M Conjugate, 100 ug |
|||
00068 | Biotium | 1UG | EUR 236 |
Description: N/A |
Cholera Toxin B, CF®405M Conjugate, 100 ug |
|||
00068-1 | Biotium | EA | EUR 236 |
Cholera Toxin B, CF®647 Conjugate, 100 ug |
|||
00069 | Biotium | 1UG | EUR 236 |
Description: N/A |
Cholera Toxin B, CF®647 Conjugate, 100 ug |
|||
00069-1 | Biotium | EA | EUR 236 |
A total of 291 patients treated from June 2007 to June 2017 and met the inclusion criteria were included in this study. The clinical diagnosis of MCTD is made on 111 patients, of whom 103 (92.8%) were women. Mean age at presentation was 39.3 years (SD ± 11.6). The most common organ system involved is the musculoskeletal system (95.5%), skin and mucosa (78.4%), and gastrointestinal and hepatobiliary system (56%).